SCHEMBL18256710

SCHEMBL18256710

Cn1c(=O)n(CC2(C)COC2)c(=O)c2c1ncn2CC1CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.51
▸ TRPA1 O75762 4/20 0.42
▸ POLB P06746 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ ADORA2B P29275 5/20 0.40
▸ MAPT P10636 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ PDE4A P27815 2/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ ADORA2A P29274 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19601312 0.86 KMT2A (0.50) KMT2ATRPA1POLBHIF1AADORA2B
SCHEMBL20205697 0.85 KMT2A (0.47) KMT2ATRPA1POLBHIF1AADORA2B
SCHEMBL20205786 0.84 KMT2A (0.46) KMT2ATRPA1POLBHIF1AADORA2B
SCHEMBL18256622 0.83 SMN1; SMN2 (0.49) KMT2ATRPA1POLBHIF1ALMNA
SCHEMBL18256643 0.83 ADORA2B (0.56) POLBADORA2BLMNAPDE4ACYP1A2
SCHEMBL18256623 0.83 KMT2A (0.43) KMT2ATRPA1POLBHIF1AADORA2B
SCHEMBL20205776 0.82 LMNA (0.43) KMT2ATRPA1POLBHIF1ALMNA
SCHEMBL18256066 0.81 KMT2A (0.60) KMT2APOLBADORA2BMAPTLMNA
SCHEMBL17682211 0.81 KMT2A (0.45) KMT2ATRPA1POLBHIF1AADORA2B
SCHEMBL17682304 0.79 KMT2A (0.54) KMT2ATRPA1POLBHIF1AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10618898-B2 Hydroxyl purine compounds and use thereof Guangdong Raynovent Biotech Co., Ltd. (CN) 2020-04-14 — — US disclosed
US-20180148451-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF Guangdong Raynovent Biotech Co., Ltd. (CN) 2018-05-31 — — US disclosed
US-20180148451-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF Guangdong Raynovent Biotech Co., Ltd. (CN) 2018-05-31 — — US disclosed
WO-2016184313-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF 南京明德新药研发股份有限公司 2016-11-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148451-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF PNP, PDE7A, PDE2A KMT2A 3573/4885TRPA1 3059/4885POLB 403/4885
US-10618898-B2 Hydroxyl purine compounds and use thereof PNP, PDE7A, PDE2A KMT2A 3573/4885TRPA1 3059/4885POLB 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback